tiprankstipranks
BioRestorative Therapies (BRTX)
NASDAQ:BRTX
Holding BRTX?
Track your performance easily

BioRestorative Therapies (BRTX) Financial Statements

170 Followers

BioRestorative Therapies Financial Overview

BioRestorative Therapies's market cap is currently ―. The company's EPS TTM is $-0.714; its P/E ratio is -1.96; BioRestorative Therapies is scheduled to report earnings on May 20, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Sep 23Jun 23
Income Statement-
Total Revenue$ 233.60K$ 89.10K$ 35.00K$ 30.70K$ 64.50K
Gross Profit$ 215.36K$ 82.61K$ 35.00K$ 30.70K$ 64.50K
EBIT$ -1.25M$ -4.20M$ -2.36M$ -3.02M$ -5.81M
EBITDA$ -1.20M$ -4.16M$ -2.32M$ -2.98M$ -5.76M
Net Income Common Stockholders$ -1.09M$ -4.03M$ -3.93M$ -2.93M$ -5.71M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 13.09M$ 14.68M$ 16.42M$ 12.24M$ 11.62M
Total Assets$ 14.57M$ 16.12M$ 17.95M$ 13.80M$ 13.30M
Total Debt$ 42.41K$ 83.58K$ 123.54K$ 198.72K$ 234.06K
Net Debt$ -13.05M$ -14.60M$ -16.29M$ -12.04M$ -11.38M
Total Liabilities$ 4.58M$ 5.32M$ 3.45M$ 975.03K$ 896.43K
Stockholders Equity$ 9.99M$ 10.80M$ 14.50M$ 12.83M$ 12.40M
Cash Flow-
Free Cash Flow$ -1.76M$ -1.94M$ -2.30M$ -1.19M$ -1.31M
Operating Cash Flow$ -1.70M$ -1.90M$ -2.30M$ -1.18M$ -1.28M
Investing Cash Flow$ 936.75K$ 2.97M$ -4.93M$ -23.06K$ 819.03K
Financing Cash Flow-$ -12.84K$ 7.52M$ 1.85M$ 411.70K
Currency in USD

BioRestorative Therapies Earnings and Revenue History

BioRestorative Therapies Debt to Assets

BioRestorative Therapies Cash Flow

BioRestorative Therapies Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis